SHILPA MEDICARE LTD. - 530549 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Reporting (BRSR) for the F.Y 2022-2305-09-2023
05-09-2023
SHILPA MEDICARE LTD. - 530549 - 36Th Annual General Meeting Of Shilpa Medicare Limited Is Scheduled On Friday, The 29Th Day Of September 2023 At 11:00 AM
We are pleased to inform you that 36th Annual General Meeting of Shilpa Medicare Limited is scheduled on Friday, the 29th day of September 2023 at 11:00 AM through video conferencing (VC)/ other audio visual means (OAVM). Cutoff date for determining the list of members for voting and participation at AGM is set as Friday, 22 September 2023. Book closure - Saturday, 23 September 2023 to Friday, 29 September 202302-09-2023
SHILPA MEDICARE LTD. - 530549 - Shilpa Pharma Lifesciences Ltd, Unit II, Raichur, Karnataka Has Cleared PMDA Japan, GMP Inspection
Shilpa Medicare Limited''s 100% subsidiary, SPL - API Manufacturing facilty has undergone GMP Inspection without any critical / major observation01-09-2023
SHILPA MEDICARE LTD. - 530549 - Intimation U/R 30 Of The SEBI(LODR) Regulations -UK-MHRA Approval For Betahistine Dihydrochloride Orodispersible Films, 24 Mg
This is to inform you that shilpa medicare limited, headquartered at Raichur, Karnataka, India, has received Marketing Authorisation from MHRA, UK, for Betahistine Dihydrochloride Orodispersible Films, 24 mg. Shilpa is the first company to receive approval for the 24mg strength as a film formulation in UK. Shilpa''s approval is a hybrid product application, which is bio-equivalent to the reference product.01-09-2023
SHILPA MEDICARE LTD. - 530549 - Board Meeting Outcome for Regulation 33, 34 And 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
This is to inform that the Board of Directors at their meeting held on 01 September 2023 which commenced at 11.20 and concluded at 13:30 have inter alia consider and approved :- 1. The Annual Report for the Financial Year 2022-23. 2. Annual General Meeting of the Members of the Company: We are pleased to inform you that the 36th Annual General Meeting of Shilpa Medicare Limited is scheduled on Friday, the 29th day of September 2023 at 11:00 AM through video conferencing (VC)/ other audio visual means (OAVM) to transact the business(es) as set forth in the notice of the meeting.01-09-2023
SHILPA MEDICARE LTD. - 530549 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August 29, 2023 for Deepak Kumar Innani & Others30-08-2023
SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 29, 2023 for Deepak Kumar Innani30-08-2023
SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 29, 2023 for Deepak Kumar Innani30-08-2023
SHILPA MEDICARE LTD. - 530549 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
POSTAL BALLOT OUTCOME & SCRUTINIZER REPORT30-08-2023
SHILPA MEDICARE LTD. - 530549 - RELEASE OF PLEDGE OF SHARES OF MEMBER OF THE PROMOTER GROUP
Disclosure on Release of pledge of 400000 shares of Mr. Deepak Kumar Innani (Member of Promoter Group)29-08-2023